George Pavey

George Pavey is currently a Board Member at Rejuvenate Biomed. Prior to this, they served as the Chief Financial Officer at AC Immune SA from July 2015 to January 2017. During their time there, they successfully concluded two pre-IPO financing rounds raising a total of $43.5 million from leading dedicated healthcare investors. George also completed a $76 million IPO on Nasdaq which was more than 10x oversubscribed and traded up over 50% in the week after listing. In addition, they prepared the company for listing in the US, coordinating the activities of the underwriters, legal advisors, accountants and other advisors / parties (such as transfer agent, printers, Nasdaq).

Before AC Immune SA, George Pavey worked at HSBC in Hong Kong from May 2005 to August 2007 as the Co-Head of Global Capital Markets, Asia-Pacific. In this role, they were responsible for equity and debt capital markets in Asia with a primary focus on equity capital markets origination (IPOs, Follow-On Offerings, accelerated placements) as well as convertible bond origination. Some of their key completed offerings during their time at HSBC include the $2.2bn Bank of Communications IPO, $2.8bn Link REIT IPO, $1.8bn China Cosco IPO, $750m Khazanah/Telekom Malaysia exchangeable bond offering, $880m IPO of Shui On Land and $506m Capitacommercial Trust follow on offering. In 2007, their key transactions included the $5.9bn

George Pavey completed a Bachelor of Arts in Business Administration and Management, General at Ivey Business School at Western University. George also holds a certification from the CFA Institute in CFA.